Jean-Marc Vandoorne, CEO of Biobest said: "Our acquisition of IVOG capital, completed in the last days of 2017, marked the end of a spectacular year for Biobest in terms of growth, with similar contributions from internal growth and mergers and acquisitions. IVOG is an old and much appreciated partner. This transaction will allow us to become more involved in the manufacture of the increasingly important product line of sticky traps and tape. Our stake in IVOG's capital will facilitate joint investments in innovative quality products and state-of-the-art production technologies. Our visions are well aligned and I look forward to continuing our collaboration with Joachim Schneider and his team in this new environment."
Biobest acquires majority stake in IVOG
Jean-Marc Vandoorne, CEO of Biobest said: "Our acquisition of IVOG capital, completed in the last days of 2017, marked the end of a spectacular year for Biobest in terms of growth, with similar contributions from internal growth and mergers and acquisitions. IVOG is an old and much appreciated partner. This transaction will allow us to become more involved in the manufacture of the increasingly important product line of sticky traps and tape. Our stake in IVOG's capital will facilitate joint investments in innovative quality products and state-of-the-art production technologies. Our visions are well aligned and I look forward to continuing our collaboration with Joachim Schneider and his team in this new environment."